Solid Biosciences LLC (SLDB) — Financial Flexibility Index
Solid Biosciences LLC (SLDB) has a Financial Flexibility Index of -0.60x as of September 2025. Free cash flow of $-33.39 Million (operating CF $-33.47 Million minus capex $85.00K) represents -1% of total liabilities ($55.97 Million). Also explore Solid Biosciences LLC equity growth rate to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Solid Biosciences LLC Financial Flexibility Index (2015–2024)
Historical Financial Flexibility Index trend for Solid Biosciences LLC across 10 annual periods. Check strategic asset allocation of Solid Biosciences LLC to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Solid Biosciences LLC (2015–2024)
Year-by-year free cash flow to debt coverage for Solid Biosciences LLC. For the full company profile including market capitalisation, see Solid Biosciences LLC (SLDB) total market value.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -1.93x | $-99.36 Million | $-100.01 Million | $51.42 Million | ▲ +19.8% |
| 2023 | -2.41x | $-92.67 Million | $-94.18 Million | $38.46 Million | ▼ -23.3% |
| 2022 | -1.95x | $-94.96 Million | $-97.98 Million | $48.59 Million | ▲ +38.2% |
| 2021 | -3.16x | $-76.48 Million | $-77.76 Million | $24.17 Million | ▼ -122.0% |
| 2020 | -1.43x | $-55.70 Million | $-56.60 Million | $39.08 Million | ▲ +62.2% |
| 2019 | -3.77x | $-88.33 Million | $-92.71 Million | $23.42 Million | ▲ +12.9% |
| 2018 | -4.33x | $-62.42 Million | $-70.20 Million | $14.41 Million | ▼ -1332.5% |
| 2017 | -0.30x | $-40.95 Million | $-43.22 Million | $135.45 Million | ▼ -20.3% |
| 2016 | -0.25x | $-19.73 Million | $-20.12 Million | $78.52 Million | ▼ -398.4% |
| 2015 | -0.05x | $-3.81 Million | $-4.20 Million | $75.62 Million | — |